LOVFF Cannara Biotech Inc.
Stock Price & Overview

$0.700.00 (0.00%)9:30 AM 10/02/23

OTCQB | $USD | Market Close

Quant Ranking

Analysis

News

Latest Headlines

Cannara Biotech GAAP EPS of C$0.03, revenue of C$15.94M

Cannara Biotech GAAP EPS of -$0.01, revenue of $13M

Cannara Biotech reports Q1 results

Cannara Biotech announces repurchase of common shares

Cannara Biotech GAAP EPS of C$0.01, revenue of C$11.89M

Cannara Biotech director Derek Stern acquired 720K shares

Cannara enters exclusive brand partnership with Exotic Genetix in Canada

Cannara Biotech GAAP EPS of $0.01, revenue of $10.1M

Cannara Biotech GAAP EPS of -C$0.01, revenue of C$7.42M

Cannara Biotech GAAP EPS of -C$0.01, revenue of C$6.56M

Company Profile

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

Sector

Health Care

Industry

Pharmaceuticals

Employees

Founded

2017

Address